Cargando…

Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression

Emerging evidence supports the pivotal roles of cancer-associated cachexia in breast cancer progression. However, the mediators and mechanisms that mediate cancer-induced cachexia remain unclear. Here, we show that breast cancer-derived exosomes alter adipocytes and muscle cells in terms of increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qi, Sun, Si, Li, Zhiyu, Yang, Qian, Li, Bei, Zhu, Shan, Wang, Lijun, Wu, Juan, Yuan, Jingping, Yang, Changhua, Li, Juanjuan, Sun, Shengrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201501/
https://www.ncbi.nlm.nih.gov/pubmed/30359265
http://dx.doi.org/10.1186/s12943-018-0899-5
_version_ 1783365515534663680
author Wu, Qi
Sun, Si
Li, Zhiyu
Yang, Qian
Li, Bei
Zhu, Shan
Wang, Lijun
Wu, Juan
Yuan, Jingping
Yang, Changhua
Li, Juanjuan
Sun, Shengrong
author_facet Wu, Qi
Sun, Si
Li, Zhiyu
Yang, Qian
Li, Bei
Zhu, Shan
Wang, Lijun
Wu, Juan
Yuan, Jingping
Yang, Changhua
Li, Juanjuan
Sun, Shengrong
author_sort Wu, Qi
collection PubMed
description Emerging evidence supports the pivotal roles of cancer-associated cachexia in breast cancer progression. However, the mediators and mechanisms that mediate cancer-induced cachexia remain unclear. Here, we show that breast cancer-derived exosomes alter adipocytes and muscle cells in terms of increased catabolism characterized by the release of metabolites. Likewise, tumour cells cocultivated with mature adipocytes or C2C12 exhibit an aggressive phenotype through inducing epithelial-mesenchymal transition. Mechanistically, we show that cancer cell-secreted miR-155 promotes beige/brown differentiation and remodel metabolism in resident adipocytes by downregulating the PPARγ expression, but does not significantly affect biological conversion in C2C12. In vitro the use of propranolol ameliorates tumour exosomes-associated cachectic wasting through upregulating the PPARγ expression. These results demonstrate that cancer-derived exosomes reprogram systemic energy metabolism and accelerate cancer-associated cachexia to facilitate tumour progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12943-018-0899-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6201501
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62015012018-10-31 Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression Wu, Qi Sun, Si Li, Zhiyu Yang, Qian Li, Bei Zhu, Shan Wang, Lijun Wu, Juan Yuan, Jingping Yang, Changhua Li, Juanjuan Sun, Shengrong Mol Cancer Letter to the Editor Emerging evidence supports the pivotal roles of cancer-associated cachexia in breast cancer progression. However, the mediators and mechanisms that mediate cancer-induced cachexia remain unclear. Here, we show that breast cancer-derived exosomes alter adipocytes and muscle cells in terms of increased catabolism characterized by the release of metabolites. Likewise, tumour cells cocultivated with mature adipocytes or C2C12 exhibit an aggressive phenotype through inducing epithelial-mesenchymal transition. Mechanistically, we show that cancer cell-secreted miR-155 promotes beige/brown differentiation and remodel metabolism in resident adipocytes by downregulating the PPARγ expression, but does not significantly affect biological conversion in C2C12. In vitro the use of propranolol ameliorates tumour exosomes-associated cachectic wasting through upregulating the PPARγ expression. These results demonstrate that cancer-derived exosomes reprogram systemic energy metabolism and accelerate cancer-associated cachexia to facilitate tumour progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12943-018-0899-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-25 /pmc/articles/PMC6201501/ /pubmed/30359265 http://dx.doi.org/10.1186/s12943-018-0899-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to the Editor
Wu, Qi
Sun, Si
Li, Zhiyu
Yang, Qian
Li, Bei
Zhu, Shan
Wang, Lijun
Wu, Juan
Yuan, Jingping
Yang, Changhua
Li, Juanjuan
Sun, Shengrong
Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
title Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
title_full Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
title_fullStr Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
title_full_unstemmed Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
title_short Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
title_sort tumour-originated exosomal mir-155 triggers cancer-associated cachexia to promote tumour progression
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201501/
https://www.ncbi.nlm.nih.gov/pubmed/30359265
http://dx.doi.org/10.1186/s12943-018-0899-5
work_keys_str_mv AT wuqi tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression
AT sunsi tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression
AT lizhiyu tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression
AT yangqian tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression
AT libei tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression
AT zhushan tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression
AT wanglijun tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression
AT wujuan tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression
AT yuanjingping tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression
AT yangchanghua tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression
AT lijuanjuan tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression
AT sunshengrong tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression